In pre-specified subgroup analyses, patients with the highest plasma drug concentrations showed a positive trend towards improvement relative to placebo on both HVLT and WMS.
← all excerpts
Alzheimer's disease and neuroinflammation: will new drugs in clinical trials pave the way to a multi-target therapy?
1
—
—